Skip to content
Menu

Jefferies Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $40

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsInitiationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Jefferies analyst Faisal Khurshid initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $40.

Jefferies analyst Faisal Khurshid initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $40.

Read at benzinga.com